Clinical Trials Browser

OTHER × Ferrosoferric Oxide × CNS × Clear all

NCT07461948 2026-03-10

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

Phase 3 Recruiting

Glioblastoma

NCT03270059 2026-02-27

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2 Recruiting

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms

NCT04900792 2025-12-03

XACT-Fe-GBM-01

Phase 1 Active not recruiting

Glioblastoma

NCT03347617 2025-09-09

Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma

Phase 2 Terminated

52 enrolled 15 charts

Glioblastoma

NCT00659126 2023-09-07

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Phase 2 Terminated

40 enrolled 8 charts

Brain Neoplasms

NCT03179449 2023-04-14

In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI

Phase EARLY_PHASE1 Withdrawn

Childhood Brain Neoplasm

NCT00978562 2022-08-03

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

Phase EARLY_PHASE1 Completed

14 enrolled 8 charts

Childhood Brain Neoplasm

NCT00103038 2022-06-09

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Phase NA Completed

155 enrolled 11 charts

Brain Neoplasms, Glioma

NCT02359097 2022-03-17

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Phase NA Completed

Glioblastoma

NCT03234309 2021-11-10

Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors

Phase 2 Withdrawn

Brain Neoplasms

NCT02466828 2018-04-18

qBOLD MRI of Glioblastoma Multiforme for Assessment of Tumor Hypoxia.

Phase EARLY_PHASE1 Completed

Hypoxia, Glioblastoma

NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Phase EARLY_PHASE1 Completed

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

NCT00660543 2017-05-16

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

Phase NA Completed

14 enrolled 6 charts

Adult Brain Glioblastoma

NCT00769093 2017-04-21

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

Phase 1 Terminated

Brain Neoplasms